konfluierende hepatische Fibrose
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/6/7/3/000030_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/2/0/9/000004_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/data.pacs.de/1/0/8/3/5/8/IMG-0002-00013_big_gallery_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/6/7/6/000007_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/6/7/8/000014_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/6/7/9/000008_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/6/8/2/000021_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/6/8/5/000026_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/6/8/6/000029_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/6/8/7/000031_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/6/8/8/000034_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/6/8/9/000035_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/6/7/5/000006_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/2/1/3/000002_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/2/1/1/000003_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/2/1/4/000006_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/2/1/8/000010_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/2/1/9/000011_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/2/2/0/000012_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/2/2/1/000013_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/2/2/2/000014_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/2/2/3/000015_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/2/2/5/000017_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/2/2/6/000019_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/www.eurorad.org/9/6/2/2/9/000022_thumb.jpg)
![](https://pacs.de/sites/default/files/pictures/thumbs/data.pacs.de/1/0/8/3/8/9/13244_2010_34_Fig9_HTML_thumb.jpg)
Confluent hepatic fibrosis is a possible result of chronic injury to the liver, most commonly from cirrhosis or hepatic vascular injury.
Radiographic features
Confluent hepatic fibrosis is a cause of wedge-shaped or concave-marginated abnormalities in the cirrhotic liver: it occurs more frequently in the medial and anterior segments of the liver and tends to extend from the hilum to the periphery.
CT
- wedge-shaped regions of hypoattenuation on non-contrast CT
- hypoattenuating on the arterial and portal venous phases
- the fibrosis may gradually enhance
MRI
- wedge-shaped regions of moderate T2 hyperintensity
- T1 hypointensity (possible increased T1 signal from cholestasis)
- progressive postcontrast enhancement on the dynamic sequence but does not show enhancement on the delayed phase with hepatospecific contrast agents
- lack fat signal intensity
Confluent hepatic fibrosis is categorized as LR1 or LR2 in the LI-RADS classification system. If findings are indeterminate between fibrosis and hepatocellular carcinoma, it should be graded LR3 or LR4.
Differential diagnosis
The main differential diagnoses are:
- hepatocellular carcinoma
- enhancement pattern allows differentiation
- not associated with volume loss or capsular retraction
- cholangiocarcinoma
- peripheral cholangiocarcinoma may also show capsular retraction but generally is more masslike
- dilated intrahepatic bile ducts are also more common in cholangiocarcinoma than with confluent hepatic fibrosis
- hepatic epithelioid hemangioendothelioma
- may show capsular retraction but otherwise has a different appearance and enhancement pattern
Practical points
For unknown reasons, confluent fibrosis is more common in primary sclerosing cholangitis and alcohol-related cirrhosis than with viral cirrhosis.
Siehe auch:
![Click für weniger anzeigen](/sites/all/modules/pacs/tools/imgs/collapse_up.png)
![](/sites/all/modules/pacs/tools/imgs/Iris_color_40.png)